Correction to: Montelukast inhibits abdominal aortic aneurysm formation in mice via activating the AMPK/mTOR signalling pathway.

IF 1.8 3区医学 Q2 SURGERY Langenbeck's Archives of Surgery Pub Date : 2025-02-06 DOI:10.1007/s00423-025-03625-8

Jian Huang, Jiawei Zhuang, Jiamao Wang, Zhonggui Shan

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正：孟鲁司特通过激活AMPK/mTOR信号通路抑制小鼠腹主动脉瘤形成。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Langenbeck's Archives of Surgery 医学-外科

CiteScore

3.30

自引率

8.70%

发文量

342

审稿时长

4-8 weeks

期刊介绍： Langenbeck''s Archives of Surgery aims to publish the best results in the field of clinical surgery and basic surgical research. The main focus is on providing the highest level of clinical research and clinically relevant basic research. The journal, published exclusively in English, will provide an international discussion forum for the controlled results of clinical surgery. The majority of published contributions will be original articles reporting on clinical data from general and visceral surgery, while endocrine surgery will also be covered. Papers on basic surgical principles from the fields of traumatology, vascular and thoracic surgery are also welcome. Evidence-based medicine is an important criterion for the acceptance of papers.

期刊最新文献

Simulation unlocked: transforming thyroid surgery training through high-fidelity and curriculum-based innovation-a systematic review. Changes in psoas muscle area in patients with colorectal cancer three years after surgery: a longitudinal approach. Correction to: Risk and protective factors for anastomotic insufficiency in elective colon and rectal cancer resections - a multivariate analysis with over 700 patients. Current German practices in the prevention and management of postoperative pancreatic fistula following pancreatoduodenectomy: a nationwide survey. Outcomes of patients with rectal cancer and pathological complete response as well as patients with tumor cell dedifferentiation. Two prognostic different groups of patients responding to pre-operative oncological therapy.